Tsukamoto K - Search Results

1

CD4+CD25high regulatory T cells are markedly decreased in blood of patients with pemphigus vulgaris.

Sugiyama H, Matsue H, Nagasaka A, Nakamura Y, Tsukamoto K, Shibagaki N, Kawamura T, Kitamura R, Ando N, Shimada S. Sugiyama H, et al. Among authors: tsukamoto k. Dermatology. 2007;214(3):210-20. doi: 10.1159/000099585. Dermatology. 2007. PMID: 17377382

2

gp100 mRNA is more sensitive than tyrosinase mRNA for RT-PCR amplification to detect circulating melanoma cells in peripheral blood of melanoma patients.

Tsukamoto K, Ueda M, Hirata S, Osada A, Kitamura R, Takahashi T, Ichihashi M, Shimada S. Tsukamoto K, et al. J Dermatol Sci. 2000 Jun;23(2):126-31. doi: 10.1016/s0923-1811(99)00098-5. J Dermatol Sci. 2000. PMID: 10808130

3

Detection of circulating melanoma cells by RT-PCR amplification of three different melanocyte-specific mRNAs in a mouse model.

Tsukamoto K, Hirata S, Osada A, Kitamura R, Shimada S. Tsukamoto K, et al. Pigment Cell Res. 2000 Jun;13(3):185-9. doi: 10.1034/j.1600-0749.2000.130311.x. Pigment Cell Res. 2000. PMID: 10885678

4

A case of lymphoepithelioma-like carcinoma of the skin associated with Epstein-Barr virus infection.

Aoki R, Mitsui H, Harada K, Kawamura T, Shibagaki N, Tsukamoto K, Murata S, Shimada S. Aoki R, et al. Among authors: tsukamoto k. J Am Acad Dermatol. 2010 Apr;62(4):681-4. doi: 10.1016/j.jaad.2008.07.024. J Am Acad Dermatol. 2010. PMID: 20227583

5

Generalized melanosis in metastatic malignant melanoma: the possible role of DOPAquinone metabolites.

Tsukamoto K, Furue M, Sato Y, Takayama O, Akasu R, Ohtake N, Wakamatsu K, Ito S, Tamaki K, Shimada S. Tsukamoto K, et al. Dermatology. 1998;197(4):338-42. doi: 10.1159/000018028. Dermatology. 1998. PMID: 9873171

6

Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis: role of SCF/KIT protein interactions and the downstream effector, MITF-M.

Kitamura R, Tsukamoto K, Harada K, Shimizu A, Shimada S, Kobayashi T, Imokawa G. Kitamura R, et al. Among authors: tsukamoto k. J Pathol. 2004 Apr;202(4):463-75. doi: 10.1002/path.1538. J Pathol. 2004. PMID: 15095274

7

Improving chemotherapeutic drug penetration in melanoma by imatinib mesylate.

Ogawa Y, Kawamura T, Furuhashi M, Tsukamoto K, Shimada S. Ogawa Y, et al. Among authors: tsukamoto k. J Dermatol Sci. 2008 Sep;51(3):190-9. doi: 10.1016/j.jdermsci.2008.03.011. Epub 2008 May 15. J Dermatol Sci. 2008. PMID: 18485676

8

Impetigo herpetiformis with IL-36RN mutation successfully treated with secukinumab.

Kinoshita M, Ogawa Y, Takeichi T, Okamoto T, Osada A, Shimada S, Sugiura K, Akiyama M, Kawamura T, Tsukamoto K. Kinoshita M, et al. Among authors: tsukamoto k. Eur J Dermatol. 2018 Jun 1;28(3):381-382. doi: 10.1684/ejd.2018.3259. Eur J Dermatol. 2018. PMID: 30105995 No abstract available.

9

Successful use of etretinate for long-term management of a patient with cutaneous-type adult T-cell leukaemia/lymphoma.

Inozume T, Matsue H, Furuhashi M, Nakamura Y, Mitsui H, Ando N, Mitzutani M, Miyahara A, Kawamura T, Shibagaki N, Tsukamoto K, Shimada S. Inozume T, et al. Among authors: tsukamoto k. Br J Dermatol. 2005 Dec;153(6):1239-41. doi: 10.1111/j.1365-2133.2005.06974.x. Br J Dermatol. 2005. PMID: 16307674 No abstract available.

10

Approaches to repigmentation of vitiligo skin: new treatment with ultrasonic abrasion, seed-grafting and psoralen plus ultraviolet A therapy.

Tsukamoto K, Osada A, Kitamura R, Ohkouchi M, Shimada S, Takayama O. Tsukamoto K, et al. Pigment Cell Res. 2002 Oct;15(5):331-4. doi: 10.1034/j.1600-0749.2002.02034.x. Pigment Cell Res. 2002. PMID: 12213088 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,028 results

Search Page

Filters